Finding a cure
In 2010, 35.6 million people in the world were living with Alzheimer’s disease. By 2030, that number is expected to double.
Today’s medicines treat the symptoms but not the cause of dementia.
It’s time for a change.
Why - the benefits
Research is the key to treating and ultimately curing Alzheimer’s disease and dementia.
That’s why the Kawartha Centre has become a leading clinical trial research site for Alzheimer’s disease.
Qualified individuals with memory concerns may be able to take part in research to help evaluate new drugs to treat Alzheimer’s disease.
“We’re very happy to contribute to medical science in finding a cure for Alzheimer’s.”
Clinical trial participant
“The research we’re supporting today may help find a cure for Alzheimer’s disease – and that might mean my children and grandchildren won’t have to worry.”
Clinical trial participant
Global network
Part of the Consortium of Canadian Centres for Clinical Cognitive Research, c5r.ca, the Kawartha Centre is a respected partner of national and international organizations committed to healthy aging and advances in treating age-related illness.
Current trials
Click here to see a list of our currently enrolling clinical trials.